AbbVie Comprehensive Income 2012-2026 | ABBV

AbbVie comprehensive income for the quarter ending March 31, 2026 was $-1.574B, a 32.56% decline year-over-year.

  • AbbVie comprehensive income for 2024 was $-1.925B, a 16.49% decline from 2023.
  • AbbVie comprehensive income for 2023 was $-2.305B, a 4.82% increase from 2022.
  • AbbVie comprehensive income for 2022 was $-2.199B, a 24.15% decline from 2021.

AbbVie Comprehensive Income 2012-2026 | ABBV

  • AbbVie comprehensive income for 2024 was $-1.925B, a 16.49% decline from 2023.
  • AbbVie comprehensive income for 2023 was $-2.305B, a 4.82% increase from 2022.
  • AbbVie comprehensive income for 2022 was $-2.199B, a 24.15% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B